韩国开始试行《安乐死法》 年满19岁可填写意向书

2017-10-23 佚名 环球网

韩国《亚洲经济》援引韩国保健福祉部22日消息称,从10月23日至明年1月15日将试行《维持生命医疗决定法》(也称《安乐死法》),临终患者可以自己决定是否继续接受维持生命的治疗。维持生命的医疗是指,对医学上已经判定治愈无望的临终病人进行的仅用来维持生命体征的治疗。根据《维持生命医疗决定法》,从明年2月起,如果主治医师及相关领域的1名专家从医学的角度判断患者已经处于临终期,治愈无望,那么患者可以自己决

韩国《亚洲经济》援引韩国保健福祉部22日消息称,从10月23日至明年1月15日将试行《维持生命医疗决定法》(也称《安乐死法》),临终患者可以自己决定是否继续接受维持生命的治疗。

维持生命的医疗是指,对医学上已经判定治愈无望的临终病人进行的仅用来维持生命体征的治疗。

根据《维持生命医疗决定法》,从明年2月起,如果主治医师及相关领域的1名专家从医学的角度判断患者已经处于临终期,治愈无望,那么患者可以自己决定是否接受心肺复苏、血液透析、抗癌及人工呼吸器4种维持生命的治疗。

但前提是患者必须通过填写“事前维持生命医疗意向书”和“维持生命医疗计划书”明确表明不接受维持生命的治疗。

法案试行工作分为两个部分,一是事前维持生命医疗意向书的相关资讯、填写及登记;二是填写及执行维持生命医疗计划书。

凡年满19岁的成人,不论是否患有疾病,都可以填写事前意向书。该资料在患者未来被判定无治疗意义,即将死亡时,可作为拒绝维持生命治疗的资料使用。

未填写事前意向书,但病情已至末期,处于临终阶段的患者可要求医生填写维持生命医疗计划书。

尽管《维持生命医疗决定法》正式实行在即,患者、家属、医疗团队及普通人对该法案的理解还不够。今年3月健康保险政策研究院进行的问卷调查结果显示,知道该法案存在的普通人仅有15.6%,医疗团队33.6%,患者及家属37.2%。

为此,韩国福祉部计划通过此次试行加大对该法案的宣传,减少法案正式实行的混乱。

2009年,韩国正式为一名处于植物人状态的患者摘除呼吸机,实施韩国首例“尊严死”。在韩国,相对“安乐死”而言,“尊严死”一词使用更为普遍,其含义也略有不同。它仅指放弃给患者治疗、任由患者自然死亡的“消极的安乐死”,而不包括注射药物帮助患者死亡的“积极的安乐死”。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1334821, encodeId=f4be1334821a8, content=<a href='/topic/show?id=d16910002215' target=_blank style='color:#2F92EE;'>#韩国#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100022, encryptionId=d16910002215, topicName=韩国)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99cf2500102, createdName=zjshifan_98647306, createdTime=Wed Oct 25 09:55:00 CST 2017, time=2017-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443025, encodeId=8b20144302577, content=<a href='/topic/show?id=6e7a4568e9e' target=_blank style='color:#2F92EE;'>#安乐死#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45687, encryptionId=6e7a4568e9e, topicName=安乐死)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e175016637, createdName=ms7524819409032184, createdTime=Wed Oct 25 09:55:00 CST 2017, time=2017-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255409, encodeId=50932554092d, content=学习一下.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Mon Oct 23 20:00:02 CST 2017, time=2017-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255392, encodeId=c44a255392f7, content=学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Mon Oct 23 19:35:08 CST 2017, time=2017-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255385, encodeId=0a0f25538538, content=韩国<亚洲经济>援引韩国保健福祉部22日消息称.从10月23日至明年1月15日将试行<维持生命医疗决定法>(也称<安乐死法>).临终患者可以自己决定是否继续接受维持生命的治疗., beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Mon Oct 23 19:14:17 CST 2017, time=2017-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255373, encodeId=eff62553e32c, content=He, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e56e2177556, createdName=120664b6m45(暂无昵称), createdTime=Mon Oct 23 19:04:25 CST 2017, time=2017-10-23, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1334821, encodeId=f4be1334821a8, content=<a href='/topic/show?id=d16910002215' target=_blank style='color:#2F92EE;'>#韩国#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100022, encryptionId=d16910002215, topicName=韩国)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99cf2500102, createdName=zjshifan_98647306, createdTime=Wed Oct 25 09:55:00 CST 2017, time=2017-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443025, encodeId=8b20144302577, content=<a href='/topic/show?id=6e7a4568e9e' target=_blank style='color:#2F92EE;'>#安乐死#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45687, encryptionId=6e7a4568e9e, topicName=安乐死)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e175016637, createdName=ms7524819409032184, createdTime=Wed Oct 25 09:55:00 CST 2017, time=2017-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255409, encodeId=50932554092d, content=学习一下.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Mon Oct 23 20:00:02 CST 2017, time=2017-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255392, encodeId=c44a255392f7, content=学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Mon Oct 23 19:35:08 CST 2017, time=2017-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255385, encodeId=0a0f25538538, content=韩国<亚洲经济>援引韩国保健福祉部22日消息称.从10月23日至明年1月15日将试行<维持生命医疗决定法>(也称<安乐死法>).临终患者可以自己决定是否继续接受维持生命的治疗., beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Mon Oct 23 19:14:17 CST 2017, time=2017-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255373, encodeId=eff62553e32c, content=He, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e56e2177556, createdName=120664b6m45(暂无昵称), createdTime=Mon Oct 23 19:04:25 CST 2017, time=2017-10-23, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1334821, encodeId=f4be1334821a8, content=<a href='/topic/show?id=d16910002215' target=_blank style='color:#2F92EE;'>#韩国#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100022, encryptionId=d16910002215, topicName=韩国)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99cf2500102, createdName=zjshifan_98647306, createdTime=Wed Oct 25 09:55:00 CST 2017, time=2017-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443025, encodeId=8b20144302577, content=<a href='/topic/show?id=6e7a4568e9e' target=_blank style='color:#2F92EE;'>#安乐死#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45687, encryptionId=6e7a4568e9e, topicName=安乐死)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e175016637, createdName=ms7524819409032184, createdTime=Wed Oct 25 09:55:00 CST 2017, time=2017-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255409, encodeId=50932554092d, content=学习一下.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Mon Oct 23 20:00:02 CST 2017, time=2017-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255392, encodeId=c44a255392f7, content=学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Mon Oct 23 19:35:08 CST 2017, time=2017-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255385, encodeId=0a0f25538538, content=韩国<亚洲经济>援引韩国保健福祉部22日消息称.从10月23日至明年1月15日将试行<维持生命医疗决定法>(也称<安乐死法>).临终患者可以自己决定是否继续接受维持生命的治疗., beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Mon Oct 23 19:14:17 CST 2017, time=2017-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255373, encodeId=eff62553e32c, content=He, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e56e2177556, createdName=120664b6m45(暂无昵称), createdTime=Mon Oct 23 19:04:25 CST 2017, time=2017-10-23, status=1, ipAttribution=)]
    2017-10-23 changjiu

    学习一下.谢谢

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1334821, encodeId=f4be1334821a8, content=<a href='/topic/show?id=d16910002215' target=_blank style='color:#2F92EE;'>#韩国#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100022, encryptionId=d16910002215, topicName=韩国)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99cf2500102, createdName=zjshifan_98647306, createdTime=Wed Oct 25 09:55:00 CST 2017, time=2017-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443025, encodeId=8b20144302577, content=<a href='/topic/show?id=6e7a4568e9e' target=_blank style='color:#2F92EE;'>#安乐死#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45687, encryptionId=6e7a4568e9e, topicName=安乐死)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e175016637, createdName=ms7524819409032184, createdTime=Wed Oct 25 09:55:00 CST 2017, time=2017-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255409, encodeId=50932554092d, content=学习一下.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Mon Oct 23 20:00:02 CST 2017, time=2017-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255392, encodeId=c44a255392f7, content=学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Mon Oct 23 19:35:08 CST 2017, time=2017-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255385, encodeId=0a0f25538538, content=韩国<亚洲经济>援引韩国保健福祉部22日消息称.从10月23日至明年1月15日将试行<维持生命医疗决定法>(也称<安乐死法>).临终患者可以自己决定是否继续接受维持生命的治疗., beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Mon Oct 23 19:14:17 CST 2017, time=2017-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255373, encodeId=eff62553e32c, content=He, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e56e2177556, createdName=120664b6m45(暂无昵称), createdTime=Mon Oct 23 19:04:25 CST 2017, time=2017-10-23, status=1, ipAttribution=)]
    2017-10-23 惠映实验室

    学习了.谢谢

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1334821, encodeId=f4be1334821a8, content=<a href='/topic/show?id=d16910002215' target=_blank style='color:#2F92EE;'>#韩国#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100022, encryptionId=d16910002215, topicName=韩国)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99cf2500102, createdName=zjshifan_98647306, createdTime=Wed Oct 25 09:55:00 CST 2017, time=2017-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443025, encodeId=8b20144302577, content=<a href='/topic/show?id=6e7a4568e9e' target=_blank style='color:#2F92EE;'>#安乐死#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45687, encryptionId=6e7a4568e9e, topicName=安乐死)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e175016637, createdName=ms7524819409032184, createdTime=Wed Oct 25 09:55:00 CST 2017, time=2017-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255409, encodeId=50932554092d, content=学习一下.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Mon Oct 23 20:00:02 CST 2017, time=2017-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255392, encodeId=c44a255392f7, content=学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Mon Oct 23 19:35:08 CST 2017, time=2017-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255385, encodeId=0a0f25538538, content=韩国<亚洲经济>援引韩国保健福祉部22日消息称.从10月23日至明年1月15日将试行<维持生命医疗决定法>(也称<安乐死法>).临终患者可以自己决定是否继续接受维持生命的治疗., beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Mon Oct 23 19:14:17 CST 2017, time=2017-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255373, encodeId=eff62553e32c, content=He, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e56e2177556, createdName=120664b6m45(暂无昵称), createdTime=Mon Oct 23 19:04:25 CST 2017, time=2017-10-23, status=1, ipAttribution=)]
    2017-10-23 有备才能无患

    韩国<亚洲经济>援引韩国保健福祉部22日消息称.从10月23日至明年1月15日将试行<维持生命医疗决定法>(也称<安乐死法>).临终患者可以自己决定是否继续接受维持生命的治疗.

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1334821, encodeId=f4be1334821a8, content=<a href='/topic/show?id=d16910002215' target=_blank style='color:#2F92EE;'>#韩国#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100022, encryptionId=d16910002215, topicName=韩国)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99cf2500102, createdName=zjshifan_98647306, createdTime=Wed Oct 25 09:55:00 CST 2017, time=2017-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443025, encodeId=8b20144302577, content=<a href='/topic/show?id=6e7a4568e9e' target=_blank style='color:#2F92EE;'>#安乐死#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45687, encryptionId=6e7a4568e9e, topicName=安乐死)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e175016637, createdName=ms7524819409032184, createdTime=Wed Oct 25 09:55:00 CST 2017, time=2017-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255409, encodeId=50932554092d, content=学习一下.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Mon Oct 23 20:00:02 CST 2017, time=2017-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255392, encodeId=c44a255392f7, content=学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Mon Oct 23 19:35:08 CST 2017, time=2017-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255385, encodeId=0a0f25538538, content=韩国<亚洲经济>援引韩国保健福祉部22日消息称.从10月23日至明年1月15日将试行<维持生命医疗决定法>(也称<安乐死法>).临终患者可以自己决定是否继续接受维持生命的治疗., beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Mon Oct 23 19:14:17 CST 2017, time=2017-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255373, encodeId=eff62553e32c, content=He, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e56e2177556, createdName=120664b6m45(暂无昵称), createdTime=Mon Oct 23 19:04:25 CST 2017, time=2017-10-23, status=1, ipAttribution=)]

相关资讯

我们又晚一步?韩国拍穿越剧宣传中医

一提起穿越剧,人们多半会联想到俗套的爱情故事。可这部韩国穿越剧却以其中的医疗情节勾起人们的兴趣。 近日,韩国tvN电视台就播出了一部以中医为主题的穿越剧。 据韩联社报道,在这部名为《名不虚传》的电视剧中,来自17世纪朝鲜王朝时期的医生许任是当时最好的针灸师,但因受挫而愤世嫉俗,机缘巧合来到400多年后的首尔,遇到现代外科医生崔燕京,双方从而展开一场传统与现代医学的交流。 在剧中,古代医生

韩国实施新医疗法 医闹**可判5年罚千万韩元

韩国保健福祉部表示,从12日开始实施修改后的医疗法。该法新增了一项旨在禁止恐吓或施暴医疗人员的条款,即任何人不得在医疗场所对正在进行医疗行为的医疗人员施暴或恐吓,违者将处以5年以下有期徒刑或2000万韩元(约合10万人民币)以下罚款。

韩国咳嗽诊疗指南(中文版)

咳嗽是许多呼吸道疾病的最常见症状之一。韩国结核病与呼吸病研究院组织成立了咳嗽指南委员会并由该委员会制定了咳嗽指南。该指南旨在指导临床医生正确诊断和有效治疗咳嗽。 本文提供咳嗽诊疗建议及指南概要,同时提供一套有关急性、亚急性、慢性咳嗽的诊疗方案。对于慢性咳嗽,需要考虑上气道咳嗽综合征(UACS)、咳嗽变异型哮喘(CVA)、胃食管反流性疾病(GERD)。如果疑诊UACS,可经验性使用第一

诺华制药在韩国因不合规被惨罚,营销合规不能“抄小道”

这两天韩国“卫计委”官员放风说要加大对诺华制药去年不合规营销行为的处罚,包括对涉案药品强制降价。去年八月诺华韩国爆出通过第三方(主要是医学杂志)以会议形式向医生行贿的丑闻,包括诺华韩国总裁在内的六名高管、15 名医生和 5 家医学期刊的头头被调查。诺华被罚了 18 万美金还有 12 个产品被全国停药三个月(好像很少有药品是临床非用不可的),涉案医生据说也要被吊销行医执照(太惨了,韩国医生可不容易当

我们又晚一步?韩国拍穿越剧宣传中医……

一提起穿越剧,人们多半会联想到俗套的爱情故事。可这部韩国穿越剧却以其中的医疗情节勾起人们的兴趣。近日,韩国tvN电视台就播出了一部以中医为主题的穿越剧。

Ann Lab Med:韩国第一例由PROM1突变导致STGD4被发现!

韩国首尔Sungkyunkwan大学医学院三星医学中心眼科系的Kim JM近日在Ann Lab Med杂志发表了一篇文章,题目为"Identification of the PROM1 Mutation p.R373C in a Korean Patient With Autosomal Dominant Stargardt-like Macular Dystrophy",他们报道了韩国第一例由P